Clinical Trial Update: FARE Augmentation of Proximal Femoral Fractures With CaS/HA and Systemic ZA [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update from Aksaray University evaluating augmentation of proximal femoral fractures with a CaS/HA bone graft substitute plus systemic zo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Fracture
• Oste Osteoporosis
• Osteoporotic Fracture of Femur
• Trochanteric Fracture of Femur

Drugs mentioned

• Calcium sulfate/hydroxyapatite bone graft substitute (CaS/HA) (calcium sulfate/hydroxyapatite bone graft substitute)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Aksaray University | Conditions: Trochanteric Fracture of Femur, Osteoporotic Fracture of Femur | Phase 4 | Status: COMPLETED